Sumeet A Khetarpal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoprotein C-III | 8 | 2020 | 203 | 1.740 |
Why?
|
Triglycerides | 11 | 2021 | 2447 | 1.620 |
Why?
|
Lipoproteins | 5 | 2021 | 880 | 1.460 |
Why?
|
Cholesterol, HDL | 10 | 2018 | 1807 | 1.310 |
Why?
|
Lipase | 4 | 2021 | 315 | 1.280 |
Why?
|
N-Acetylgalactosaminyltransferases | 3 | 2020 | 66 | 0.780 |
Why?
|
Lipolysis | 1 | 2021 | 211 | 0.740 |
Why?
|
Hyperlipoproteinemia Type I | 1 | 2019 | 7 | 0.740 |
Why?
|
Primary Prevention | 2 | 2021 | 1165 | 0.590 |
Why?
|
Secondary Prevention | 1 | 2021 | 1516 | 0.510 |
Why?
|
Open Reading Frames | 1 | 2018 | 810 | 0.510 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 782 | 0.490 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3233 | 0.480 |
Why?
|
Mutation, Missense | 2 | 2021 | 2552 | 0.420 |
Why?
|
Coronary Disease | 6 | 2017 | 6068 | 0.420 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 643 | 0.410 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1170 | 0.410 |
Why?
|
Lipid Metabolism | 4 | 2017 | 1891 | 0.400 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1174 | 0.380 |
Why?
|
Coronary Vessels | 1 | 2021 | 3097 | 0.360 |
Why?
|
Coronary Artery Disease | 5 | 2021 | 6416 | 0.360 |
Why?
|
Hematopoiesis | 1 | 2019 | 2049 | 0.360 |
Why?
|
Cholesterol, LDL | 2 | 2016 | 2334 | 0.350 |
Why?
|
Atherosclerosis | 3 | 2021 | 3401 | 0.330 |
Why?
|
Proteomics | 2 | 2017 | 3584 | 0.290 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3364 | 0.290 |
Why?
|
Lipoproteins, VLDL | 2 | 2017 | 201 | 0.280 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15070 | 0.250 |
Why?
|
Lipoprotein(a) | 2 | 2021 | 424 | 0.240 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 15500 | 0.230 |
Why?
|
Homozygote | 3 | 2017 | 1788 | 0.230 |
Why?
|
Postprandial Period | 2 | 2021 | 293 | 0.210 |
Why?
|
Apolipoproteins | 2 | 2017 | 315 | 0.210 |
Why?
|
Lysophosphatidylcholines | 1 | 2021 | 81 | 0.200 |
Why?
|
Aging | 1 | 2019 | 8613 | 0.180 |
Why?
|
Mutation | 5 | 2019 | 29658 | 0.180 |
Why?
|
Phenotype | 7 | 2019 | 16301 | 0.180 |
Why?
|
Amidohydrolases | 1 | 2019 | 171 | 0.170 |
Why?
|
Gene Frequency | 3 | 2017 | 3585 | 0.160 |
Why?
|
Liposomes | 1 | 2021 | 760 | 0.160 |
Why?
|
Mice, Knockout | 6 | 2021 | 14558 | 0.150 |
Why?
|
Oligonucleotides | 1 | 2019 | 572 | 0.140 |
Why?
|
PPAR gamma | 1 | 2019 | 494 | 0.140 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 82 | 0.140 |
Why?
|
Angiopoietins | 1 | 2016 | 80 | 0.140 |
Why?
|
Apolipoproteins B | 1 | 2017 | 373 | 0.130 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2016 | 91 | 0.130 |
Why?
|
Consanguinity | 1 | 2017 | 456 | 0.130 |
Why?
|
Apolipoproteins A | 1 | 2015 | 92 | 0.130 |
Why?
|
Docosahexaenoic Acids | 1 | 2021 | 873 | 0.120 |
Why?
|
Lipoprotein Lipase | 1 | 2015 | 126 | 0.120 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 432 | 0.120 |
Why?
|
ADAM Proteins | 1 | 2015 | 242 | 0.120 |
Why?
|
Immunoblotting | 1 | 2017 | 1683 | 0.120 |
Why?
|
Receptors, LDL | 1 | 2016 | 472 | 0.120 |
Why?
|
Primates | 1 | 2016 | 544 | 0.120 |
Why?
|
Ear, External | 1 | 2014 | 161 | 0.120 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 977 | 0.120 |
Why?
|
Mice | 10 | 2021 | 81002 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1898 | 0.110 |
Why?
|
Genetic Variation | 5 | 2019 | 6539 | 0.110 |
Why?
|
Adipocytes | 1 | 2019 | 1171 | 0.110 |
Why?
|
Humans | 27 | 2021 | 739398 | 0.110 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1654 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1445 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4182 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1156 | 0.100 |
Why?
|
Animals | 12 | 2021 | 168368 | 0.100 |
Why?
|
Genes, Regulator | 1 | 2011 | 378 | 0.090 |
Why?
|
5' Untranslated Regions | 1 | 2011 | 250 | 0.090 |
Why?
|
Genotype | 2 | 2017 | 12951 | 0.090 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2694 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 606 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2200 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 821 | 0.090 |
Why?
|
Genome-Wide Association Study | 4 | 2018 | 12178 | 0.090 |
Why?
|
Molecular Targeted Therapy | 3 | 2017 | 2727 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2164 | 0.090 |
Why?
|
Drug Design | 1 | 2015 | 1088 | 0.090 |
Why?
|
Risk Factors | 6 | 2021 | 71974 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2757 | 0.080 |
Why?
|
Glycosylation | 3 | 2020 | 1125 | 0.080 |
Why?
|
Up-Regulation | 2 | 2015 | 4205 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2259 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1721 | 0.080 |
Why?
|
Coronary Stenosis | 1 | 2014 | 836 | 0.080 |
Why?
|
Male | 17 | 2021 | 349022 | 0.080 |
Why?
|
Dyslipidemias | 1 | 2015 | 851 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2184 | 0.080 |
Why?
|
Liver | 3 | 2021 | 7449 | 0.080 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13816 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2900 | 0.070 |
Why?
|
Middle Aged | 11 | 2021 | 212863 | 0.070 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2017 | 127 | 0.060 |
Why?
|
Haplotypes | 1 | 2011 | 2782 | 0.060 |
Why?
|
Base Sequence | 1 | 2016 | 12804 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9734 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17384 | 0.060 |
Why?
|
Alleles | 2 | 2014 | 6942 | 0.060 |
Why?
|
Rats | 2 | 2020 | 24270 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3571 | 0.060 |
Why?
|
Computer Simulation | 1 | 2017 | 6237 | 0.060 |
Why?
|
Gene Expression | 2 | 2019 | 7788 | 0.060 |
Why?
|
Female | 13 | 2021 | 378853 | 0.050 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2021 | 31 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 11699 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 24714 | 0.050 |
Why?
|
Pedigree | 2 | 2020 | 4640 | 0.050 |
Why?
|
Aged | 8 | 2017 | 162698 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9259 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5863 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2015 | 1549 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20055 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1793 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 35 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 782 | 0.040 |
Why?
|
Adult | 6 | 2018 | 213394 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2019 | 474 | 0.030 |
Why?
|
Pakistan | 1 | 2017 | 293 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2017 | 209 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 2 | 2016 | 1991 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1015 | 0.030 |
Why?
|
Philadelphia | 1 | 2015 | 262 | 0.030 |
Why?
|
Hydrolysis | 1 | 2016 | 682 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2015 | 392 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4174 | 0.030 |
Why?
|
Leucine | 1 | 2016 | 560 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26345 | 0.030 |
Why?
|
Lipogenesis | 1 | 2016 | 210 | 0.030 |
Why?
|
Glycopeptides | 1 | 2015 | 223 | 0.030 |
Why?
|
Proline | 1 | 2016 | 454 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 685 | 0.030 |
Why?
|
Subtilisins | 1 | 2014 | 83 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 316 | 0.030 |
Why?
|
Genetic Code | 1 | 2014 | 158 | 0.030 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 591 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 950 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2015 | 1798 | 0.020 |
Why?
|
Cohort Studies | 4 | 2017 | 40389 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2012 | 572 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1587 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 21507 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 2257 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12049 | 0.020 |
Why?
|
Heterozygote | 1 | 2016 | 2798 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1186 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2013 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1082 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2440 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2208 | 0.020 |
Why?
|
Heart Diseases | 1 | 2021 | 2782 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5181 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2012 | 1108 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3280 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2118 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1778 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12761 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2272 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2009 | 1528 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4400 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9684 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21863 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5948 | 0.010 |
Why?
|
Exons | 1 | 2009 | 2430 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20913 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4791 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18125 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4560 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18003 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6237 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2012 | 3180 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 13880 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40802 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 12643 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11668 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56255 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23355 | 0.010 |
Why?
|
Child | 1 | 2020 | 77033 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 85405 | 0.010 |
Why?
|